Aging-associated cellular metabolic reprogramming in the pathogenesis of systemic sclerosis: current progress and therapeutic perspectives

Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease characterized by microvascular injury, immune dysregulation, and progressive fibrosis affecting the skin and internal organs. The disease typically develops between 45 and 60 years of age, and patients with late-onset SSc often experience more aggressive disease progression and poorer clinical outcomes. Despite advances in disease management, effective therapies targeting the underlying pathogenic mechanisms remain limited. Emerging evidence suggests that metabolic alterations associated with aging, cellular senescence, and SSc may interact to influence fibroblast activation, endothelial dysfunction, immune-cell responses, and extracellular matrix remodeling. Alterations in glucose, lipid, amino acid, and mitochondrial metabolism have been reported in SSc and experimental models of fibrosis; however, their causal relationships with biological aging and disease progression vary in evidential strength. This review summarizes current evidence on metabolic remodeling in key cellular populations involved in SSc, discusses potential interactions among cellular senescence, metabolic regulation, and the fibrotic microenvironment, and evaluates emerging metabolism-targeted therapeutic strategies. Particular attention is given to distinguishing findings established in SSc from mechanisms inferred from aging research or other fibrotic diseases. A clearer understanding of these relationships may help identify disease-relevant metabolic pathways and guide future mechanistic and translational studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.2007061
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Aging-associated cellular metabolic reprogramming in the pathogenesis of systemic sclerosis: current progress and therapeutic perspectives

Hongyan Wen, Xuwei Hou, Shaochen Zhang, Hao Cheng et al.
2 links
Frontiers in Immunology
Systemic Sclerosis and Related Diseases
article

Aging-associated cellular metabolic reprogramming in the pathogenesis of systemic sclerosis: current progress and therapeutic perspectives

Hongyan Wen, Xuwei Hou, Shaochen Zhang, Hao Cheng, Zhuojie Zhang
article en

Abstract

Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease characterized by microvascular injury, immune dysregulation, and progressive fibrosis affecting the skin and internal organs. The disease typically develops between 45 and 60 years of age, and patients with late-onset SSc often experience more aggressive disease progression and poorer clinical outcomes. Despite advances in disease management, effective therapies targeting the underlying pathogenic mechanisms remain limited. Emerging evidence suggests that metabolic alterations associated with aging, cellular senescence, and SSc may interact to influence fibroblast activation, endothelial dysfunction, immune-cell responses, and extracellular matrix remodeling. Alterations in glucose, lipid, amino acid, and mitochondrial metabolism have been reported in SSc and experimental models of fibrosis; however, their causal relationships with biological aging and disease progression vary in evidential strength. This review summarizes current evidence on metabolic remodeling in key cellular populations involved in SSc, discusses potential interactions among cellular senescence, metabolic regulation, and the fibrotic microenvironment, and evaluates emerging metabolism-targeted therapeutic strategies. Particular attention is given to distinguishing findings established in SSc from mechanisms inferred from aging research or other fibrotic diseases. A clearer understanding of these relationships may help identify disease-relevant metabolic pathways and guide future mechanistic and translational studies.

Frontiers in ImmunologyVol. 17
Shanxi Medical University (CN), First Hospital of Shanxi Medical University (CN)
Good health and well-being
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon